DrugPatentWatch Database Preview

Details for Patent: 8,579,865

« Back to Dashboard

Which drugs does patent 8,579,865 protect, and when does it expire?

Patent 8,579,865 protects OTREXUP and is included in one NDA.

This patent has twelve patent family members in seven countries.

Summary for Patent: 8,579,865

Title:	Hazardous agent injection system
Abstract:	Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
Inventor(s):	Wotton; Paul (Stamford, CT), Sadowski; Peter L. (Woodbury, MN), Hayes; John William (Chaska, MN)
Assignee:	Antares Pharma, Inc. (Ewing, NJ)
Application Number:	13/257,555
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 8,579,865
Patent Claim Types: see list of patent claims	Dosage form; Use;

Drugs Protected by US Patent 8,579,865

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-005	Nov 7, 2014		DISCN	Yes	No			Y			SUBCUTANEOUS INJECTION OF METHOTREXATE
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-001	Oct 11, 2013		RX	Yes	Yes			Y			SUBCUTANEOUS INJECTION OF METHOTREXATE
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-006	Mar 24, 2016		RX	Yes	Yes			Y			SUBCUTANEOUS INJECTION OF METHOTREXATE
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-002	Oct 11, 2013		RX	Yes	Yes			Y			SUBCUTANEOUS INJECTION OF METHOTREXATE
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-007	Mar 24, 2016		RX	Yes	Yes			Y			SUBCUTANEOUS INJECTION OF METHOTREXATE
Antares Pharma Inc	OTREXUP	methotrexate	SOLUTION;SUBCUTANEOUS	204824-003	Oct 11, 2013		RX	Yes	Yes			Y			SUBCUTANEOUS INJECTION OF METHOTREXATE

Foreign Priority and PCT Information for Patent: 8,579,865

PCT Information
PCT Filed	March 19, 2010	PCT Application Number:	PCT/US2010/028011
PCT Publication Date:	September 23, 2010	PCT Publication Number:	WO2010/108116

International Family Members for US Patent 8,579,865

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010226442
Canada	2755779
China	102612381
European Patent Office	2408493
Japan	2012521224
Japan	2015042270